Literature DB >> 19201841

LAG-3 regulates plasmacytoid dendritic cell homeostasis.

Creg J Workman1, Yao Wang, Karim C El Kasmi, Drew M Pardoll, Peter J Murray, Charles G Drake, Dario A A Vignali.   

Abstract

Lymphocyte activation gene 3 (LAG-3) is a CD4-related, activation-induced cell surface molecule expressed by various lymphoid cell types and binds to MHC class II with high affinity. We have previously shown that LAG-3 negatively regulates the expansion of activated T cells and T cell homeostasis, and is required for maximal regulatory T cell function. In this study, we demonstrate for the first time that LAG-3 is also expressed on CD11c(low)/B220(+)/PDCA-1(+) plasmacytoid dendritic cells (pDCs). Lag3 expression, as determined by real time PCR, was approximately 10-fold greater in pDCs than in either regulatory T cells or activated T effector cells. Activated pDCs also generate approximately 5 times more sLAG-3 than activated T cells. LAG-3-deficient pDCs proliferate and expand more than wild-type pDCs in vivo in response to the TLR9 ligand, CpG. However, the effect of LAG-3 appears to be selective as there was no effect of LAG-3 on the expression of MHC class II, TLR9, and chemokine receptors, or on cytokine production. Lastly, adoptive transfer of either Lag3(+/+) or Lag3(-/-) T cells plus or minus Lag3(+/+) or Lag3(-/-) pDCs defined a role for LAG-3 in controlling pDC homeostasis as well as highlighting the consequences of deregulated Lag3(-/-) pDCs on T cell homeostasis. This raised the possibility of homeostatic reciprocity between T cells and pDCs. Collectively, our data suggests that LAG-3 plays an important but selective cell intrinsic and cell extrinsic role in pDC biology, and may serve as a key functional marker for their study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19201841      PMCID: PMC2675170          DOI: 10.4049/jimmunol.0800185

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

Review 1.  Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets.

Authors:  Masataka Kuwana
Journal:  Hum Immunol       Date:  2002-12       Impact factor: 2.850

2.  Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology.

Authors:  C Asselin-Paturel; A Boonstra; M Dalod; I Durand; N Yessaad; C Dezutter-Dambuyant; A Vicari; A O'Garra; C Biron; F Brière; G Trinchieri
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

3.  The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells.

Authors:  Creg J Workman; Dario A A Vignali
Journal:  Eur J Immunol       Date:  2003-04       Impact factor: 5.532

4.  Metalloproteases regulate T-cell proliferation and effector function via LAG-3.

Authors:  Nianyu Li; Yao Wang; Karen Forbes; Kate M Vignali; Bret S Heale; Paul Saftig; Dieter Hartmann; Roy A Black; John J Rossi; Carl P Blobel; Peter J Dempsey; Creg J Workman; Dario A A Vignali
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

5.  Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice.

Authors:  P Björck
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

6.  Cutting edge: molecular analysis of the negative regulatory function of lymphocyte activation gene-3.

Authors:  Creg J Workman; Kari J Dugger; Dario A A Vignali
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

7.  Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation.

Authors:  P Hwu; M X Du; R Lapointe; M Do; M W Taylor; H A Young
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

8.  Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3).

Authors:  Creg J Workman; Dennis S Rice; Kari J Dugger; Cornelia Kurschner; Dario A A Vignali
Journal:  Eur J Immunol       Date:  2002-08       Impact factor: 5.532

9.  Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus.

Authors:  Meredith O'Keeffe; Hubertus Hochrein; David Vremec; Irina Caminschi; Joanna L Miller; E Margot Anders; Li Wu; Mireille H Lahoud; Sandrine Henri; Bernadette Scott; Paul Hertzog; Lilliana Tatarczuch; Ken Shortman
Journal:  J Exp Med       Date:  2002-11-18       Impact factor: 14.307

10.  The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor.

Authors:  Michel Gilliet; Andre Boonstra; Carine Paturel; Svetlana Antonenko; Xiu-Ling Xu; Giorgio Trinchieri; Anne O'Garra; Yong-Jun Liu
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

View more
  92 in total

1.  LAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L.

Authors:  Carrie L Lucas; Creg J Workman; Semir Beyaz; Samuel LoCascio; Guiling Zhao; Dario A A Vignali; Megan Sykes
Journal:  Blood       Date:  2011-03-21       Impact factor: 22.113

Review 2.  Making cold malignant pleural effusions hot: driving novel immunotherapies.

Authors:  Pranav Murthy; Chigozirim N Ekeke; Kira L Russell; Samuel C Butler; Yue Wang; James D Luketich; Adam C Soloff; Rajeev Dhupar; Michael T Lotze
Journal:  Oncoimmunology       Date:  2019-01-22       Impact factor: 8.110

Review 3.  Limitations and opportunities for immune checkpoint inhibitors in pediatric malignancies.

Authors:  Jeong A Park; Nai-Kong V Cheung
Journal:  Cancer Treat Rev       Date:  2017-06-01       Impact factor: 12.111

4.  CRISPR-Cas9 mediated LAG-3 disruption in CAR-T cells.

Authors:  Yongping Zhang; Xingying Zhang; Chen Cheng; Wei Mu; Xiaojuan Liu; Na Li; Xiaofei Wei; Xiang Liu; Changqing Xia; Haoyi Wang
Journal:  Front Med       Date:  2017-06-17       Impact factor: 4.592

Review 5.  Dendritic cells in systemic lupus erythematosus.

Authors:  Heather M Seitz; Glenn K Matsushima
Journal:  Int Rev Immunol       Date:  2010-04       Impact factor: 5.311

6.  Alternative activation of human plasmacytoid DCs in vitro and in melanoma lesions: involvement of LAG-3.

Authors:  Chiara Camisaschi; Annamaria De Filippo; Valeria Beretta; Barbara Vergani; Antonello Villa; Elisabetta Vergani; Mario Santinami; Antonello Domenico Cabras; Flavio Arienti; Frédéric Triebel; Monica Rodolfo; Licia Rivoltini; Chiara Castelli
Journal:  J Invest Dermatol       Date:  2014-01-17       Impact factor: 8.551

Review 7.  The plasmacytoid dendritic cell as the Swiss army knife of the immune system: molecular regulation of its multifaceted functions.

Authors:  Julien J Karrich; Loes C M Jachimowski; Christel H Uittenbogaart; Bianca Blom
Journal:  J Immunol       Date:  2014-12-15       Impact factor: 5.422

8.  Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma.

Authors:  Anne Fröhlich; Judith Sirokay; Simon Fietz; Timo J Vogt; Jörn Dietrich; Romina Zarbl; Mike Florin; Pia Kuster; Gonzalo Saavedra; Susana Ramírez Valladolid; Friederike Hoffmann; Lukas Flatz; Sandra S Ring; Carsten Golletz; Torsten Pietsch; Sebastian Strieth; Peter Brossart; Gerrit H Gielen; Glen Kristiansen; Friedrich Bootz; Jennifer Landsberg; Dimo Dietrich
Journal:  EBioMedicine       Date:  2020-08-30       Impact factor: 8.143

Review 9.  The Potential Role of Inhibitory Receptors in the Treatment of Psoriasis.

Authors:  Neha Shah; Sabina Sandigursky; Adam Mor
Journal:  Bull Hosp Jt Dis (2013)       Date:  2017-05

Review 10.  Tim-3, Lag-3, and TIGIT.

Authors:  Nicole Joller; Vijay K Kuchroo
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.